Use of older donor livers is associated with more extensive ischemic damage on intraoperative biopsies during liver transplantation

Liver Transplantation and Surgery

Volumn 5, Issue 5, 1999, Pages 357-361

  Deschenes, M ^a   Forbes, C ^a   Tchervenkov, J ^a   Barkun, J ^a   Metrakos, P ^a   Tector, J ^a   Alpert, E ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; DISEASE SEVERITY; FEMALE; GRAFT FAILURE; HOSPITALIZATION; HUMAN; LIVER ISCHEMIA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; PRIORITY JOURNAL; RISK FACTOR;

EID: 0032881360     PISSN: 10743022     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.500050501     Document Type: Article

References (23)

1. 1 Starzl TE, Demetris AJ, Van Thiel D. Liver transplantation. N Engl J Med 1989 ; 321: 1014–1022, 1092–1099. MEDLINE
2. 2 Guo TJ, Daily OP, Davies DB. The UNOS OPTN waiting list: 1988 to 1994. United Network for Organ Sharing. Organ Procurement and Transplantation Network. Clinical Transpl 1994 ; 69–86.
3. 3 Strasberg SM, Howard TK, Molmenti EP, Hertl M. Selecting the donor liver: Risk factors for poor function after orthotopic liver transplantation. Hepatology 1994 ; 20: 829–838. MEDLINE
4. 4 Hoofnagle JH, Lombardero M, Zetterman RK, Lake J, Porayko M, Everhart J, et al. Donor age and outcome of liver transplantation. Hepatology 1996 ; 24: 89–96. MEDLINE
5. 5 Deschenes M, Belle SH, Krom RAF, Zetterman RK, Lake JR. Early allograft dysfunction following liver transplantation: A definition and predictors of outcome. Transplantation 1998 ; 66: 302–310. MEDLINE
6. 6 Howard KH, Klintmalm GBG, Cofer JB, Husberg BS, Goldstein RM, Gonwa TA. The influence of preservation injury on rejection in the hepatic transplant patient. Transplantation 1990 ; 49: 103–107. MEDLINE
7. 7 Ploeg RJ, D'Alessandro AM, Knechtle SJ, Stegall MD, Pirsch JD, Hoffman RM, et al. Risk factors for primary dysfunction after liver transplantation: A multivariate analysis. Transplantation 1993 ; 55: 807–813. MEDLINE
8. 8 Cillo U, Tedeschi U, Carraro P, Burra P, Varagnolo M, Ambrosino G, et al. Early predictive markers of irreversible graft dysfunction after liver transplantation. Transplant Proc 1994 ; 26: 3599–3601. MEDLINE
9. 9 Deschenes M, Kelly S, Roberts JP, Lake JR. Early allograft dysfunction model predicts the cost of liver transplantation [abstr]. Gastroenterology 1997 ; 112: A1256.
10. 10 Kakizoe S, Yanaga K, Starzl TE, Demetris J. Evaluation of protocol before transplantation and after reperfusion biopsies from human orthotopic liver allografts: Considerations of preservation and early immunological injury. Hepatology 1990 ; 11: 932–941. MEDLINE
11. 11 Gaffey MJ, Boyd JC, Traweek ST, Ali MA, Rezeig M, Caldwell SH, et al. Predictive value of intraoperative biopsies and liver function tests for preservation injury in orthotopic liver transplantation. Hepatology 1997 ; 25: 184–189. MEDLINE
12. 12 Selvin S. Multivariate regression. In: Selvin S (ed). Practical biostatistical methods. California: Wadsworth, 1995 ; 95–137.
13. 13 Popper H. Aging and the liver. Prog Liver Dis 1986 ; 8: 659–683. MEDLINE
14. 14 Muller‐Hocker J, Aust D, Rohrbach H, Napiwotzky J, Reith A, Link TA, et al. Defects of the respiratory chain in the normal human liver and in cirrhosis during aging. Hepatology 1997 ; 26: 709–719. MEDLINE
15. 15 Greig PD, Forster J, Superina RA, Strasberg SM, Mohamed M, Blendis LM, et al. Donor‐specific factors predict graft function following liver transplantation. Transplant Proc 1990 ; 22: 2072–2073. MEDLINE
16. 16 Buckel E, Sandez‐Urdazpal L, Steers J, Sterioff S, Wiesner R, Krom RAF. Impaired initial function in liver grafts from donors >50 years of age. Transplant Proc 1993 ; 25: 1558–1559. MEDLINE
17. 17 Alexander JW, Vaughn WK. The use of marginal donors for organ transplantation. The influence of donor age on outcome. Transplantation 1991 ; 51: 135–141. MEDLINE
18. 18 Tillery W, Demetris AJ, Watkins D, Goldstein R, Poplawski S, Husberg BS, et al. Pathologic recognition of preservation injury in hepatic allografts with six months follow‐up. Transplant Proc 1989 ; 21: 1330–1331. MEDLINE
19. 19 Deschenes M, Belle S, Roberts JP, Lake JR. Development and testing of a predictive model for early allograft dysfunction after liver transplantation [abstr]. Hepatology 1996 ; 24: 181A.
20. 20 Lanir A, Jenkins L, Caldwell C, Lee RGL, Khettry U, Clouse ME. Hepatic transplantation survival: Correlation with adenosine nucleotide level in donor liver. Hepatology 1988 ; 8: 471–475. MEDLINE
21. 21 Kamiike W, Burdelski M, Steinhoff G, Ringe B, Lauchart W, Pichlmayr R. Adenosine nucleotide metabolism and its relation to organ viability in human liver transplantation. Transplantation 1988 ; 45: 138–143. MEDLINE
22. 22 Cywes R, Greig PD, Sanabria JR, Clavien PA, Levy GA, Harvey PR, et al. Effect of intraportal glucose infusion on hepatic glycogen content and degradation, and outcome of liver transplantation. Ann Surg 1992 ; 216: 235–247. MEDLINE
23. 23 Yamaoka Y, Washida M, Manaka D, Gubernatis G, Ringe B, Ozaki N, et al. Arterial ketone body ratio as a predictor of donor liver viability in human liver transplantation. Transplantation 1993 ; 55: 92–95. MEDLINE